Health Condition 1: H520- Hypermetropia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Residual hyperopia of more than or equal to + 0.75 D affecting visual function. Stable refraction for at least 6 months post-SMILE. Adequate corneal thickness (residual stromal bed more than or equal 280 micrometer). No signs of corneal ectasia or keratoconus. No significant ocular surface disease. No significant ocular surface disease or uncontrolled glaucoma Realistic expectations and willingness to adhere to post-op care.
Exclusion criteria
Exclusion criteria: Progressive hyperopia or unstable refraction. Irregular corneal shape (topographic signs of ectasia). Severe dry eye disease or ocular surface instability. Concurrent use of medication likely to affect interface healing Immunocompromised state/pregnancy/nursing mothers/cancer patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of efficacy of enhancement by analysing the visual outcomeTimepoint: post op day 1,14,1 month,3 month and 6 month | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To evaluate the predictability & stability of the refractive correction over time. 2.To analyze the safety profile of enhancement techniques for hyperopic SMILE, including intraoperative & postoperative complications. 3.To assess changes in corneal topography & biomechanics following enhancement. 4.To compare postoperative patient satisfaction & quality of vision before & after enhancement. Timepoint: post op day 1,14,1 month,3 month & 6 month | — |
Countries
India
Contacts
Nethradhama Super Speciality Eye Hospital